Skip to main content
. 2020 Mar 18;16(7):1533–1544. doi: 10.1080/21645515.2020.1732166

Table 2.

Mother-to-child transmission of HBV in children of HBV-infected mothers after neonatal immunoprophylaxis.

    No of HBsAg+ children/no of children (%)
 
Region Child birth year Maternal HBeAg(−) Maternal HBeAg(+) No of HBsAg+ children/total no of children (%)
Singapore86 1980s 0/670 (0) 41/345 (11.88) 41/1015 (4.0)
Taiwan87 1996–2008 4/1773 (0.23)a 54/583 (9.26) 58/2356 (2.5)
Taiwan88 2007–2013 0/364 (0) 19/162 (11.7)b 19/526 (3.6)
China, south89 2006–2010 0/887 (0) 21/473 (4.4) 21/1360 (1.5)
China, northwest90 2008–2012 0/751 (0) 39/435 (8.97) 39/1186 (3.3)
China, northeast91 2012–2015 0/565 (0) 16/306 (5.2) 16/871 (1.8)
China, central and east92 2010–2012 0/758 (0) 20/419 (4.8) 20/1177 (1.7)
China, east93 2012–2015 0/126 (0) 6/164 (3.7) 6/290 (2.1)
Hong Kong94 2014–2016 0/486 (0) 7/155 (4.5) 7/641 (1.1)
USA95 1997–2010 1/2317 (0.04) 21/624 (3.37) 22/2941 (0.7)
USA96 2007–2013 0/772 (0) 12/362 (3.3) 12/1134 (1.1)

aThree of the four HBV-infected children were not administered HBIG after birth.

bAtleast 10 of the 19 HBV-infected children were injected with hepatitis B vaccine within 2–20 d after birth, but not within 24 h after birth (Wen WH, Chang MH, Zhao LL, et al. J Hepatol. 2013;59:24–30.).